Regional variation in ICD implantation rates: The shocking truth?

Heart

Volumn 91, Issue 10, 2005, Pages 1251-1253

  Lang, Christopher C ^a  

^a ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE;

DEFIBRILLATOR; EDITORIAL; GEOGRAPHIC DISTRIBUTION; HEART ARRHYTHMIA; HEART ELECTROPHYSIOLOGY; HEART FUNCTION TEST; HEART INFARCTION; HEART LEFT VENTRICLE FAILURE; HEART VENTRICLE TACHYCARDIA; HUMAN; ISCHEMIC HEART DISEASE; PRIORITY JOURNAL; RISK FACTOR; SUDDEN DEATH; TREATMENT INDICATION; CORONARY CARE UNIT; HEALTH CARE FACILITY; NOTE; STATISTICS; UNITED KINGDOM; UTILIZATION REVIEW;

ARRHYTHMIA; CORONARY CARE UNITS; DEFIBRILLATORS, IMPLANTABLE; GREAT BRITAIN; HEALTH FACILITY SIZE; HUMANS;

EID: 25144521821     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.2004.056754     Document Type: Editorial

References (13)

1. Cunningham AD, Plummer CJ, McComb JM, et al. The implantable cardioverter-defibrillator: postcode prescribing in the UK 1998-2002. Heart 2005;91:1280-3.
2. Camm AJ, Nisam S. The utilization of the implantable defibrillator - a European enigma. Eur Heart J 2000;21:1998-2004.
3. Seidl K, Senges J. Geographic differences in implantable cardioverter defibrillator usage. J Cardiovasc Electrophysiol 2002;13(suppl 1):S100-5.
4. National Institute for Clinical Excellence. Technology Appraisal guidance - No 11. Guidance on the use of implantable cardioverter defibrillators for arrhythmias. London: NICE, September, 2000.
5. The AVID Investigators. A comparison of anti-arrhythmic drug therapy with implantable defibrillators in patients resuscitated from near fatal ventricular arrhythmias. N Engl J Med 1997;337:1576-83.
6. Connolly SJ, Gent M, Roberts RS, et al. Canadian implantable defibrillator study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation 2000;101:1297-302.
7. Moss AJ, Hall J, Cannom DS, et al for the Multicentre Automatic Defibrillator Implantation Trial (MADIT) Investigators. N Engl J Med 1996;335:1933-40.
8. Buxton AE, Lee KL, Fisher JD, et al for the Multicenter Unsustained Tachycardia Trial (MUSTT) Investigators. A randomized study of sudden death in patients with coronary artery disease. N Engl J Med 1997;341:1882-90.
9. Lyon RM, Cobbe SM, Bradley JM, et al. Surviving out of hospital cardiac arrest at home: a postcode lottery? Emerg Med 2004;21:619-24.
10. Leslie WS, Fitzpatrick B, Morrison CE, et al. Out-of-hospital cardiac arrest due to coronary heart disease: a comparison of survival before and after the introduction of defibrillators in ambulances. Heart 1996;75:195-9.
11. Plummer CJ, Irving RJ, McComb JM. Implications of national guidance for implantable cardioverter defibrillation implantation in the United Kingdom. Pacing Clin Electrophysiol 2003;26(pt 11):479-82.
12. Moss AJ, Zareba W, Hall WJ, et al for the MADIT II Investigators. Prophylactic Implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877-83.
13. Brady GH, Lee KL, Mark DB, et al for the SCD-HeFT Investigators. Amiodarone or an implantable cardioverter defibrillator for congestive heart failure. N Engl J Med 2005;352:225-37.